NCT01423526View on ClinicalTrials.gov

A Single Dose Study of DWP10292 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Healthy
Interventions
DRUG

DWP10292

Drug: DWP10292 tablets, oral administration, single administration

DRUG

Placebo

Placebo tablets, oral administration, single administrations

Trial Locations (2)

Unknown

Seoul National University Hospital, Seoul

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY